CCT measurements a must for all glaucoma patients

Article

Central corneal thickness (CCT) measurements should be carries out on all glaucoma patients in order to help set an accurate target intraocular pressure (IOP) range.

Central corneal thickness (CCT) measurements should be carries out on all glaucoma patients in order to help set an accurate target intraocular pressure (IOP) range, according to Madhu Nagar and colleagues from the Clayton Hospital, West Yorkshire, UK.

A team of researchers carried out a retrospective analysis of existing glaucoma patients at the Clayton and Dewsbury Hospitals, UK between April 2002 and September 2006. IOP was measured using Goldman Tonometry and CCT measured with a hand-held ultrasound pachymeter.

A total of 168 patients were identified for the study. The average CCT was 538.6 µm and corneas were thicker in ocular hypertension patients than in those with normal tension glaucoma. IOP measurements were also found to be higher in patients with thicker corneas. Forty-nine eyes of 35 patients had two CCT readings taken over a period of time but no clinically significant differences were found between the two measurements.

The team suggest that CCT measurements be carried out on all glaucoma patients since the results can help set accurate target IOP ranges, which can in turn help prevent over-treatment.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
© 2025 MJH Life Sciences

All rights reserved.